This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Join CSTE   |   Career Center   |   Print Page   |   Contact Us   |   Report Abuse   |   Sign In
Untitled Document

Introduction to Position Statement Process

Position Statement Timeline

Descriptions of Position Statement Types

Position Statement Submission and Review Processes

Resources

Coming Soon - Finalized approved 2018 Position Statements are coming soon

Position Statement Discussion Webinars – Members Only



  Introduction to Position Statement Process

  • Position statements allow CSTE members to standardize surveillance case definitions, maintain the Nationally Notifiable Condition List, and address policy issues that could affect state or local law, rules or regulations. Position statements are submitted each spring and then discussed and voted on by the CSTE membership at the Annual Conference in June. Position statement authors must be active CSTE members, although associate members may be co-authors.
  • There are three mechanisms to submit a position statement for consideration by the CSTE membership and discussion at the CSTE Business Meeting: ordinary process, expedited handling, and presidential review.
  • To view past CSTE position statements, please visit the Position Statement Archive.
  • Please view the Position Statement Timeline for details on each mechanism's deadline and criteria for acceptability.


  Position Statement Timeline

Position Statement Mechanism Submission Deadline Criteria for Acceptability
Ordinary Process 13 weeks before Business Meeting
  • Must be sponsored by a CSTE Active Member.
  • Must use current and appropriate position statement template.
Expedited Handling 3 weeks before Business Meeting

As judged by the current CSTE Secretary-Treasurer:

  • Issue is time-sensitive
  • Issue has substantial importance due to its impact on public health
  • The quality of the draft position statement is adequate
  • The chair of the appropriate committee agrees to accept the proposal into the Expedited Handling process.
Presidential Review Between 3 weeks and 48 hours before Business Meeting
  • Issue is extremely urgent and relevant, as judged by current CSTE President
  • Interim Position Statements: Urgent or time-sensitive issues that must be addressed between annual business meetings may be submitted as interim position statements. Interim position statements are approved by the CSTE Executive Board and immediately become official policy of CSTE until the next CSTE Business Meeting, when they must be ratified or they will become null. Interim position statements are posted to the CSTE website immediately after approval by the Executive Board.


  Descriptions of Position Statement Types

  • Policy Position Statements:
    • Policy position statements are intended for issues that would require a vote by the Council because they may result in changes to state or local law, rules or regulations. Note: All other policy issues, resolutions, etc. that would not require legal changes at the state or local level should be addressed via the process for CSTE Briefs.
    • The format of policy position statements is as follows:
      1. Statement of the problem
      2. Statement of the desired action(s) to be taken
      3. Public health impact
      4. Revision history
      5. References
      6. Coordination
      7. Author Information
    • View the 2018 Policy Position Statement Template.
    • Changes to 2018 Policy Position Statement Template
      • Appropriate Topics for Policy Position Statements: Policy position statements are intended for issues that would require a vote by the Council because they may result in changes to state or local law, rules or regulations. All other policy issues, resolutions, etc. that would not require legal changes at the state or local level should be addressed via the process for CSTE Briefs, a new process that will be announced in the upcoming weeks.
      • Subject Matter Expert (SME) Consultants: this new section has been added to allow SMEs/federal partners (e.g., CDC staff) to be listed as consultants in the position statement development process who are not considered authors. SME Consultants listed in position statements will be allowed entry to members-only voting sessions at the CSTE Annual Conference.
  • Standardized Surveillance for Diseases or Conditions Position Statements:
    • Standardized surveillance position statements are intended to standardize case definitions for diseases or conditions of importance that state and local health departments can adopt for daily surveillance activities. Each position statement contains a technical supplement that translates the narrative case definition to machine-processable logic that can be implemented in surveillance systems. These position statements also may recommend that a disease or condition be added to, updated, or removed from the Nationally Notifiable Conditions (NNC) List that CSTE and CDC maintain annually.
    • The format of standardized surveillance position statements is as follows:
      1. Statement of the problem
      2. Background and justification
      3. Statement of the desired action(s) to be taken
      4. Goals of surveillance
      5. Methods for surveillance
      6. Criteria for case ascertainment
      7. Case definition for case classification
      8. Period of surveillance
      9. Data sharing/release and print criteria
      10. Revision history
      11. References
      12. Coordination
      13. Author Information
      14. **NEW** NNC Recommendation Statement (if appropriate)
      15. **NEW** Technical Supplement (required)
    • View the 2018 Standardized Surveillance for Diseases or Conditions Position Statement Template.
    • Changes to 2018 Standardized Surveillance Position Statement Template
      • Nationally Notifiable Condition (NNC) Recommendation Statement: this new document must accompany a position statement if the position statement recommends adding a disease/condition to the NNC List or if the position statement updates a disease/condition already on the NNC List.
      • Technical Supplement: tables from template Sections VI and VII have been moved into this new Technical Supplement, which must be completed for all standardized surveillance position statements. As table completion is often a time-limiting step in developing a position statement, the Technical Supplement can be submitted no later than April 26, 2018. Authors should take the lead in developing these supplements. However, the National Office is prepared to offer one-on-one assistance in completing these technical tables.
      • Subject Matter Expert (SME) Consultants: this new section has been added to allow SMEs/federal partners (e.g., CDC staff) to be listed as consultants in the position statement development process who are not considered authors. SME Consultants listed in position statements will be allowed entry to members-only voting sessions at the CSTE Annual Conference.


  Position Statement Submission and Review Processes

  • Position Statement Development:
    • Authors seeking to update an existing standardized surveillance case definition should reference previous CSTE position statements for the condition and describe the proposed updates in the position statement.
    • Authors are also encouraged to seek input from appropriate subject matter experts at the state, local, and federal levels during the position statement writing process.
    • The template must be completed in its entirety for both updated and new case definitions.
    • Final position statements should be able to "stand alone” and contain all current information required to implement surveillance for the disease or condition.
    • To request an editable version of a position statement template, please email positionstatements@cste.org and include the type of template needed and the topic of the position statement.
  • Submission:
    • Position statements should be submitted using the appropriate template. Submitted statements using the incorrect template will not be accepted by the National Office.
    • All position statements must be submitted electronically to positionstatements@cste.org by the appropriate deadline.
  • Ordinary Process Review and Approval Process:
    • Prior to CSTE Annual Conference
      • First round: The National Office reviews all submissions for completion and shares with select group of position statement SMEs for technical review.
      • Second round: The National Office shares submissions with appropriate CSTE Executive Board members (e.g., Steering Committee Chairs), who determine if submissions should move forward for consideration by all CSTE membership and provide feedback to authors. Once feedback is received, authors may edit their submissions prior to the National Office posting to the CSTE website.
        • Please note that if the Executive Board does not approve a position statement to move forward for consideration by all membership, authors will be sufficiently notified of this decision.
      • Third round: The National Office will post approved submissions to the members-only side of the CSTE website for membership consideration prior to the CSTE Annual Conference. The National Office will also host position statement discussion webinars so authors may review their position statements with a broader audience prior to the conference.
    • At CSTE Annual Conference
      • Members are encouraged to attend the position statement discussions organized by CSTE Steering Committees, where each statement is presented by the author, discussed, and voted on. Note: An active member author is required to be at the Annual Conference to present the statement. Dates and times of the Steering Committee discussions vary but are available in the yearly CSTE Annual Conference agenda.
      • Position statements are put to two votes by the appropriate Steering Committee, the first to approve the position statement and the second to add the position statement to the CSTE Consent Calendar. The CSTE Consent Calendar is a method for position statements that have been deemed non-controversial to be voted upon all at once by the Council at the CSTE Business Meeting. In order for a Steering Committee to consider adding a position statement the CSTE Consent Calendar, a quorum of CSTE members must be met during the voting process. A quorum for position statement purposes is defined as at least one Active Member from ten or more states or U.S. territories represented in any Steering Committee Session.
      • If a position statement recommends adding a disease/condition to the NNC List or updates a disease/condition already on the NNC List, the accompanying NNC Recommendation Statement will be put to two votes as well, the first to approve the notifiability of the disease/condition and the second to add the NNC Recommendation Statement to the CSTE Consent Calendar.
      • Position statements approved by the Steering Committees are brought to the CSTE Business Meeting for final approval. This meeting occurs annually at the CSTE Annual Conference and typically occurs Thursday morning. At this meeting, representatives from state and territorial health agencies vote on the position statements. Each state and territory is given one vote.
      • Once approved, all position statements become CSTE policy and will be posted on the CSTE website. The submitting author will be responsible for tracking the position statement during the year following its adoption.


  Resources



  Submitted Position Statements and Position Statement Discussion Webinars –   Members Only

  • 2018 Position Statements (Members-Only): Click Here to View
    • 18-EH-01 – Standardized Surveillance for Carbon Monoxide Poisoning
    • 18-ID-01 – Standardized Case Definition for Surveillance of RSV-Associated Mortality
    • 18-ID-02 – Case Definition for Non-pestis Yersiniosis
    • 18-ID-03 – Revision to the Case Definition for National Diphtheria Surveillance
    • 18-ID-04 – Update to Yellow Fever Case Definition
    • 18-ID-05 – Standardized Case Definition for Candida auris Causing Clinical Infection or Colonization in People
    • 18-ID-06 – Revisions to the Surveillance Case Definition, Case Classification, Public Health Reporting, and National Notification for Listeriosis
    • 18-ID-07 – Public Health Reporting and National Notification for Hepatitis A
    • 18-ID-08 – Public Health Reporting and National Notification for Salmonella enterica serotype Typhi (S. Typhi) and Salmonella enterica serotypes Paratyphi A, B, and C (S. Paratyphi) Infections
  • CSTE has scheduled three position statement discussion webinars before the formal discussions that will take place in Steering Committee voting sessions at the 2018 CSTE Annual Conference. The purpose of these webinars is to allow more time for members and position statement authors to interact and engage in discussions of submitted position statements.
  • Webinars will be held on May 10 at 4pm-5pm ET, May 14 at 3pm-4pm ET, and May 17 at 4pm-5pm ET. Click here to see webinar details and recordings.
  • During each webinar, position statements will have a designated discussion time. During this time frame, the authors will give a 5-7 minute summary of the position statement and then CSTE members will be invited to provide feedback and discuss the position statement (up to 20 minutes per Position Statement). At the end of each webinar, participants will be encouraged to send additional feedback to the primary author. Member discussions will continue at the Annual Conference at informal roundtable sessions as well as during the formal Steering Committee voting sessions.

2018 CSTE Position Statement Discussion III
Date: May 17 at 4:00-5:00pm ET
Moderator: Rich Danila
 
Agenda
4:00: Introduction and Housekeeping
4:05: 18-ID-01 – Standardized Case Definition for Surveillance of RSV-Associated Mortality
4:20: 18-ID-07 – Public Health Reporting and National Notification for Hepatitis A
4:40: 18-ID-06 – Revisions to the Surveillance Case Definition, Case Classification, Public Health Reporting, and National Notification for Listeriosis
 
Webinar Information
To join the webinar:
1. Go to https://cste.webex.com/cste/k2/j.php?MTID=t4e65583df8a76b9a385c15c58b11f2be
2. Enter your name and email address.
3. Enter the session password: ps2018.
4. Click "Join Now".
5. Follow the audio instructions that appear on your screen.
 
To join the session by phone only:
To receive a call back, provide your phone number when you join the training session, or call the number below and enter the access code.
Call-in toll-free number (US/Canada):1-877-668-4490
Call-in toll number (US/Canada):1-408-792-6300
Access code: 791 756 372

Association Management Software Powered by YourMembership  ::  Legal